VEGF mRNA is Stabilized by Ras and Tyrosine Kinase Oncogenes, as well as by UV Radiation—Evidence for Divergent Stabilization Pathways
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Growth Factors
- Vol. 14 (2-3) , 199-212
- https://doi.org/10.3109/08977199709021520
Abstract
Vascular Endothelial Growth Factor (VEGF) is a pivotal endothelial cell mitogen that mediates both normal and pathological angiogenesis. Although expressed at very low levels in cells not undergoing vascularization, VEGF mRNA is transiently upregulated and stabilized by a variety of extracellular stimuli, and is persistently upregulated and stabilized in many human tumor cell lines (White et al., 1995). Here we demonstrate that oncogenic activation of tyrosine protein kinases and Ras proteins induce a 6-to 16-fold increase in the abundance of VEGF mRNA and a 3-to 5-fold increase in the stability of VEGF mRNA, suggesting that persistent activation of signaling pathways induced by these oncoproteins accounts for overexpression of VEGF in a significant fraction of human tumors. In addition to these oncoproteins, ultraviolet (U V) radiation upregulated and stabilized VEGF mRNA 15-and 5-fold, respectively. While the tyrosine kinase inhibitor, genistein, blocked VEGF upregulation by activated tyrosine protein kinases, and the Ras inhibitor, N-Acetyl-S-trans-farnesyl-l-cysteine (AFC), eliminated VEGF expression in cells transformed by v-Ras, neither agent blocked upregulation by hypoxia or UV radiation. These data argue that multiple divergent pathways upregulate and stabilize VEGF mRNA.Keywords
This publication has 48 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Expression and loss of heterozygosity of c-met proto-oncogene in primary breast cancerJournal of Surgical Oncology, 1995
- The Ras-related Small GTP-binding Protein RhoB Is Immediate-early Inducible by DNA Damaging TreatmentsJournal of Biological Chemistry, 1995
- HER-2/neu-targeting gene therapy-a reviewGene, 1995
- Human Melanoma Cells but Not Normal Melanocytes Express Vascular Endothelial Growth Factor ReceptorsBiochemical and Biophysical Research Communications, 1993
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Angiogenic growth factorsProgress in Growth Factor Research, 1990
- Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasoneJournal of Neurosurgery, 1987
- ras GENESAnnual Review of Biochemistry, 1987